FRANKFURT (dpa-AFX) - A sell recommendation for Redcare Pharmacy shares weighed them down in pre-market trading on Tradegate on Tuesday. The shares of the online pharmacy fell by around 9 percent to 101.10 euros compared to the Xetra close on the previous day.

In an initial assessment, the bank UBS recommended selling the shares and, with a price target of 86 euros, identified a further downside potential of around 15 percent.

The introduction of electronic prescriptions as a growth driver for the company is now "more than priced in", wrote analyst Olivier Calvet from UBS. He pointed out that the share price had recently lost around 20 percent over the month. Operational uncertainties are associated with the marketing expenses for Redcare Pharmacy's e-prescription app./bek/jha/